51白菜网彩金论坛-新人注册就送18元彩金-59博免费白菜论线路检测-免费注册领33元彩金

Pharmaceutical sector Pharmaceutical track: Pharmaceutical track

Green traditional Chinese medicine
In the track of green traditional Chinese medicine, we will, with Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (ticker symbol: SH600329) as the core enterprise, integrate plantation and processing of herbs and R&D, production and commerce of pharmaceuticals, covering the whole industrial chain of traditional Chinese medicine.
Chemical and biological pharmaceuticals
In the track of chemical and biological pharmaceuticals, we will, with Tianjin Tianyao Pharmaceuticals Co., Ltd. (ticker symbol: SH600488) as the core enterprise, are committed to building a track pattern of integrated R&D, production and sales of APIs and preparations, relying on several production bases in Tianjin Binhai New Area, Xiangyang, Hubei Province, and Yong Guang, Hebei Province.

View More

Pharmaceutical sector Medical devices: Medical devices

In the track of medical devices, we will, with MEDA Co., Ltd. and NewScen Coast Bio Pharmaceutical Co., Ltd. as the core enterprises, strive to improve the independent R&D capabilities and product technology level and build an advantageous high-end product platform.

View More

Commercial secto Commerce: Commerce

Taking Jinyao Pacific Pharmaceutical Co., Ltd. as the leader, we will cooperate with Zhongxin Pharmaceutical Plant to create a “variety + network + channel” model, apply international advanced warehousing management system and modern information technology to create an efficient drug circulation platform, and realize the “seamless connection” between the logistics industry and drug manufacturers, suppliers, downstream customers and related units.

View More

Pharmaceutical sector Consumer health: Consumer health

With Tianjin Yumeijing Group Co., Ltd. and Tianjin Puguang Medical Materials Manufacturing Co., Ltd. as the core enterprises, we will professionally develop various special products to meet the health needs of consumers and protect the health of you and your family by relying on the Group Company’s advantages in R&D, production and quality inspection of pharmaceuticals.

View More

Bioinnovation sector Assets: Assets

Taking Jinyao Asset Management Co., Ltd. as the main body, we will build a group asset and investment management platform to lay a good foundation for future capital operation.

View More

Other business segments Other business tracks: Other business tracks

With Tianjin Pharmaceutical Design Institute Co., Ltd. and Tianjin Pharmaceutical Group Finance Co., Ltd. as the core enterprises, we will be engaged in medical engineering design, group finance and fund management to serve the high-quality development of the Group Company.

View More